Theresa Dunn

522 total citations
14 papers, 421 citations indexed

About

Theresa Dunn is a scholar working on Surgery, Molecular Biology and Oncology. According to data from OpenAlex, Theresa Dunn has authored 14 papers receiving a total of 421 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Surgery, 7 papers in Molecular Biology and 5 papers in Oncology. Recurrent topics in Theresa Dunn's work include Testicular diseases and treatments (8 papers), Cancer therapeutics and mechanisms (5 papers) and Drug Transport and Resistance Mechanisms (4 papers). Theresa Dunn is often cited by papers focused on Testicular diseases and treatments (8 papers), Cancer therapeutics and mechanisms (5 papers) and Drug Transport and Resistance Mechanisms (4 papers). Theresa Dunn collaborates with scholars based in Germany, France and Hong Kong. Theresa Dunn's co-authors include Hans‐Joachim Schmoll, Carsten Bokemeyer, J. Casper, Viktor Grünwald, Kristin Hartmann, Torsten Pietsch, Udo Jonas, Markus A. Kuczyk, Pan Shu and Kevin A. W. Lee and has published in prestigious journals such as Oncogene, British Journal of Cancer and International Journal of Cancer.

In The Last Decade

Theresa Dunn

14 papers receiving 408 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Theresa Dunn Germany 10 195 147 96 95 51 14 421
DavidS. Alberts United States 9 135 0.7× 167 1.1× 71 0.7× 123 1.3× 67 1.3× 9 455
L Rausa Italy 12 202 1.0× 261 1.8× 80 0.8× 66 0.7× 70 1.4× 80 569
Merry Tetef United States 14 147 0.8× 269 1.8× 119 1.2× 86 0.9× 78 1.5× 29 581
G. R. Boniface Australia 10 182 0.9× 239 1.6× 60 0.6× 43 0.5× 39 0.8× 23 476
David L. Doering United States 13 137 0.7× 125 0.9× 54 0.6× 69 0.7× 29 0.6× 21 503
Roberta Sarmiento Italy 11 190 1.0× 235 1.6× 71 0.7× 48 0.5× 28 0.5× 19 591
H. Thomas United Kingdom 13 129 0.7× 158 1.1× 39 0.4× 79 0.8× 42 0.8× 32 427
Sylvain L’Espérance Canada 12 261 1.3× 157 1.1× 40 0.4× 76 0.8× 79 1.5× 15 530
N Saijo Japan 12 302 1.5× 277 1.9× 121 1.3× 70 0.7× 44 0.9× 25 602
Ruifang Xu China 12 198 1.0× 58 0.4× 72 0.8× 52 0.5× 56 1.1× 27 523

Countries citing papers authored by Theresa Dunn

Since Specialization
Citations

This map shows the geographic impact of Theresa Dunn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Theresa Dunn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Theresa Dunn more than expected).

Fields of papers citing papers by Theresa Dunn

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Theresa Dunn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Theresa Dunn. The network helps show where Theresa Dunn may publish in the future.

Co-authorship network of co-authors of Theresa Dunn

This figure shows the co-authorship network connecting the top 25 collaborators of Theresa Dunn. A scholar is included among the top collaborators of Theresa Dunn based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Theresa Dunn. Theresa Dunn is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Dunn, Theresa, et al.. (1998). Production and pre-clinical significance of haematopoietic peptide growth factors (HPGF) in human non-seminomatous germ cell tumour cell lines. Journal of Cancer Research and Clinical Oncology. 124(8). 435–443. 3 indexed citations
2.
Shu, Pan, et al.. (1998). The EWS/ATF1 fusion protein contains a dispersed activation domain that functions directly. Oncogene. 16(12). 1625–1631. 42 indexed citations
3.
Dunn, Theresa. (1997). Oxygen and cancer.. PubMed. 58(2). 140–3. 12 indexed citations
4.
5.
Dunn, Theresa, et al.. (1997). Comparative cytotoxicity of oxaliplatin and cisplatin in non-seminomatous germ cell cancer cell lines. Investigational New Drugs. 15(2). 109–114. 74 indexed citations
6.
Dunn, Theresa, et al.. (1997). Pre-clinical activity of taxol in non-seminomatous germ cell tumor cell lines and nude mouse xenografts. Investigational New Drugs. 15(2). 91–98. 10 indexed citations
7.
Bokemeyer, Carsten, Markus A. Kuczyk, Theresa Dunn, et al.. (1996). Expression of stem-cell factor and its receptor c-kit protein in normal testicular tissue and malignant germ-cell tumours. Journal of Cancer Research and Clinical Oncology. 122(5). 301–306. 91 indexed citations
8.
Dunn, Theresa, Hans‐Joachim Schmoll, Viktor Grünwald, Carsten Bokemeyer, & Jochen Casper. (1996). Amifostine does not alter the antitumor activity of cisplatin in a pre-clinical model of testicular cancer. Anti-Cancer Drugs. 7(7). 795–799. 13 indexed citations
9.
Dunn, Theresa, et al.. (1996). Competitive inhibition of photoaffinity labelling of P-glycoprotein by anticancer drugs and modulators including S9788. European Journal of Pharmacology. 315(3). 339–343. 8 indexed citations
10.
Bokemeyer, Carsten, et al.. (1996). Silibinin protects against cisplatin-induced nephrotoxicity without compromising cisplatin or ifosfamide anti-tumour activity. British Journal of Cancer. 74(12). 2036–2041. 55 indexed citations
11.
Bokemeyer, Carsten, Hans‐Joachim Schmoll, E. Ludwig, et al.. (1994). The anti-tumour activity of ifosfamide on heterotransplanted testicular cancer cell lines remains unaltered by the uroprotector mesna. British Journal of Cancer. 69(5). 863–867. 8 indexed citations
12.
13.
Pierré, Alain, Theresa Dunn, Laurence Kraus‐Berthier, et al.. (1992). In vitro andin vivo circumvention of multidrug resistance by Servier 9788, a novel triazinoaminopiperidine derivative. Investigational New Drugs. 10(3). 137–148. 63 indexed citations
14.
Cros, Suzy, et al.. (1992). In vivo evidence of complete circumvention of vincristine resistance by a new triazinoaminopiperidine derivative S 9788 in P388/VCR leukemia model. Cancer Chemotherapy and Pharmacology. 30(6). 491–494. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by DavidS. Alberts Breakdown of academic impact, for papers by L Rausa Breakdown of academic impact, for papers by Merry Tetef Breakdown of academic impact, for papers by G. R. Boniface Breakdown of academic impact, for papers by David L. Doering Breakdown of academic impact, for papers by Roberta Sarmiento Breakdown of academic impact, for papers by H. Thomas Breakdown of academic impact, for papers by Sylvain L’Espérance Breakdown of academic impact, for papers by N Saijo Breakdown of academic impact, for papers by Ruifang Xu
Rankless by CCL
2026